A randomized, double blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab.

Study sites:

  • UZ Antwerpen, Antwerpen
  • UZ Gent, Gent
  • CHU de Liège, Liège
  • UCL St Luc, Brussels
  • UZ Leuven, Leuven

Professional Area